Disease mechanism and biomarkers of oral squamous cell carcinoma

Purpose of review This review focuses on oral cancer disease mechanisms and discusses ongoing research to identify molecular signatures or biomarkers for oral cancer. Other areas covered include the analysis, validation, and predictive value of these markers. Recent findings During the past years, progress has been made in the oral cancer genetic markers field, which includes alterations of the p53 tumor suppressor protein, the inactivation of cyclin dependant kinase inhibitors (e.g. p16) and the overexpression of the epidermal growth factor receptor. Many of these markers are thought to have potential clinical interest, yet few of them are being used in a clinical setting for oral cancer management. The particular modifications that characterize each step of oral cancer progression can now be profiled by several high throughput discovery techniques. Genomic and proteomic studies of oral cancer tissues, plasma, and saliva of oral cancer patients, have allowed the identification of several promising cancer signatures. Summary Important progress has been made in the molecular understanding of oral cancer and its application for diagnosis, prognosis and treatment. The increased efforts in translational research will result in earlier diagnosis of oral cancer, better knowledge of prognostic factors, and the development of targeted treatment regimens based on patients' clinical and biological characteristics at presentation.

[1]  R. Nagler,et al.  Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert--first report. , 2005, Oral oncology.

[2]  B. Das,et al.  Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. , 2003, Oral oncology.

[3]  R. Ralhan,et al.  Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: Relationship with cell cycle regulators , 2006, International journal of cancer.

[4]  A. Palmieri,et al.  Potential Markers of Tongue Tumor Progression Selected by cDNA Micro Array , 2005, International journal of immunopathology and pharmacology.

[5]  J. Vishwanatha,et al.  Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia , 2005, Molecular Cancer Therapeutics.

[6]  Sunil Singhal,et al.  Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.

[7]  M. McGurk,et al.  Patient delay in oral cancer: a qualitative study of patients' experiences , 2006, Psycho-oncology.

[8]  L. Kornberg,et al.  Gene Expression Profiling in Squamous Cell Carcinoma of the Oral Cavity Shows Abnormalities in Several Signaling Pathways , 2005, The Laryngoscope.

[9]  N. Seki,et al.  Aberrant expression of RAB1A in human tongue cancer , 2005, British Journal of Cancer.

[10]  J. López,et al.  Riesgo de cáncer oral y marcadores moleculares , 2004 .

[11]  Carlos Cordon-Cardo,et al.  Molecular profiling of tumor progression in head and neck cancer. , 2005, Archives of otolaryngology--head & neck surgery.

[12]  J. Sudbø,et al.  Oral cancer prevention and the evolution of molecular-targeted drug development. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[14]  D. Tromp,et al.  Oral and pharyngeal cancer: Analysis of patient delay at different tumor stages , 2005, Head & neck.

[15]  P. Harrison,et al.  Profiling early head and neck cancer , 2005, Nature Reviews Cancer.

[16]  E. Zerhouni.  Translational and clinical science--time for a new vision. , 2005, The New England journal of medicine.

[17]  J. Sudbø.  Novel management of oral cancer: a paradigm of predictive oncology. , 2004, Clinical medicine & research.

[18]  Walter Kolch,et al.  The molecular make-up of a tumour: proteomics in cancer research. , 2005, Clinical science.

[19]  Qing‐Yu He,et al.  Identification of tumor‐associated proteins in oral tongue squamous cell carcinoma by proteomics , 2004, Proteomics.

[20]  D. Wong,et al.  Cyclin G2 Dysregulation in Human Oral Cancer , 2004, Cancer Research.

[21]  J. Fridlyand,et al.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.

[22]  J. López‐López,et al.  Oral cancer risk and molecular markers. , 2004, Medicina oral, patologia oral y cirugia bucal.

[23]  L. Chiusa,et al.  Prognostic relevance of cell proliferation in head and neck tumors. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  Qing‐Yu He,et al.  Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis , 2004, Proteomics.

[25]  D. Wong,et al.  RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.

[26]  I. Jurisica,et al.  Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis , 2004, International journal of cancer.

[27]  W. Lam,et al.  Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis , 2005, International journal of cancer.

[28]  J. Piffkó,et al.  Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? , 2004, Oral oncology.

[29]  L. Ronco,et al.  Protein biomarkers and drug design for cancer treatments , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[30]  H. Schliephake,et al.  Prognostic relevance of molecular markers of oral cancer--a review. , 2003, International journal of oral and maxillofacial surgery.

[31]  Cathie Garnis,et al.  Multiple microalterations detected at high frequency in oral cancer. , 2005, Cancer research.

[32]  Chun-Ta Liao,et al.  Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. , 2005, Clinical chemistry.

[33]  L. Mcdonald,et al.  The pathology of oral cancer , 2003, Pathology.

[34]  Brian B Haab,et al.  Antibody Arrays in Cancer Research , 2005, Molecular & Cellular Proteomics.

[35]  R. Ralhan,et al.  Alterations of Rb Pathway Components Are Frequent Events in Patients with Oral Epithelial Dysplasia and Predict Clinical Outcome in Patients with Squamous Cell Carcinoma , 2005, Oncology.

[36]  K. Jain,et al.  Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[37]  J. Kench,et al.  p14ARF Protein Expression Is a Predictor of Both Relapse and Survival in Squamous Cell Carcinoma of the Anterior Tongue , 2005, Clinical Cancer Research.

[38]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[39]  David Elashoff,et al.  Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.

[40]  B. Kramer,et al.  Molecular and genetic targets in early detection. , 1999, Current opinion in oncology.